Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2017
Patient-Derived Bladder Cancer XenograftsCarina Bernardo, Lúcio Lara SantosExpert Review of Proteomics|August 9, 2011
Glycopeptide microarray for autoantibody detection in cancerCelso A Reis, Diana Campos, Hugo Osório, et al.Advances in Experimental Medicine and Biology|October 19, 2021
The Tumour Microenvironment and Circulating Tumour Cells: A Partnership Driving Metastasis and Glycan-Based Opportunities for Cancer ControlAndreia Peixoto, Sofia Cotton, Lúcio Lara Santos, et al.Journal of Experimental & Clinical Cancer Research : CR|April 16, 2022
A roadmap for translational cancer glycoimmunology at single cell resolutionAndreia Peixoto, Andreia Miranda, Lúcio Lara Santos, et al.Biochimie|December 28, 2025
Extracellular mitochondria: a potential player involved in exercise health benefitsMafalda Barbosa Pedrosa, Lúcio Lara Santos, Rita Ferreira, et al.Porto Biomedical Journal|April 22, 2021
Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexiaPatrícia Tavares, Daniel Moreira Gonçalves, Lúcio Lara Santos, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|April 24, 2025
Glycan-based therapeutic approaches for bladder cancer: Overcoming clinical barriersRui Freitas, Andreia Peixoto, Lúcio Lara Santos, et al.BMC Medical Informatics and Decision Making|June 29, 2021
On the predictability of postoperative complications for cancer patients: a Portuguese cohort studyDaniel Gonçalves, Rui Henriques, Lúcio Lara Santos, et al.Journal of Cardiothoracic Surgery|December 5, 2025
Is the Parsimonious Eurolung risk model a good predictor for all populations? An external validation studyFilipe Leite, Ana Margarida Silva, Gonçalo Paupério, et al.Geroscience|May 22, 2026
Molecular predictors of incident frailty: a systematic review and critical appraisal of longitudinal evidenceJoão Antunes, Rita Ferreira, Lúcio Lara Santos, et al.Pageof 13